{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:52:46Z","timestamp":1781639566389,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Purpose<\/jats:title>\n                    <jats:p>Levornidazole is an ornidazole derivative effective against anaerobic pathogens. Levornidazole disodium phosphate, the disodium phosphate salt of levornidazole, exhibits higher water solubility compared to levornidazole. This study aimed to evaluate the efficacy and safety of levornidazole disodium phosphate in patients with intra-abdominal infections (IAIs) caused by anaerobic pathogens.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This non-inferiority trial enrolled patients with IAIs in China, randomized 1:1 to either 1\u2009g levornidazole disodium phosphate intravenously once daily (levornidazole group) or 0.5\u2009g ornidazole and sodium chloride intravenously twice daily (control group) for 4\u20137\u2009days. The primary endpoint was the clinical cure rate at the test-of-cure (TOC) visit. The non-inferiority margin was \u22128%. Secondary endpoints included the bacterial eradication rate, overall success rate at both TOC and the end of therapy (EOT) visits, and clinical cure rate at the EOT visit.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The full analysis set included 339 patients in the levornidazole group and 338 patients in the control group. At TOC, the clinical cure rates were 92.33% in the levornidazole group and 93.05% in the control group, with a between-group difference of \u22120.72% (95% CI: \u22124.85, 3.35). Clinical cure rates at EOT, bacteriological eradication rates, and overall success rates at EOT and TOC were similar in the two groups. The incidence of adverse drug reactions was 9.86% (34\/345) in the levornidazole group and 12.17% (42\/345) in the control group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Once-daily levornidazole disodium phosphate was non-inferior to twice-daily ornidazole and sodium chloride for treating IAI, offering a more convenient, better-tolerated option due to its lower dosing frequency.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-026-12789-7","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T02:24:38Z","timestamp":1772245478000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of levornidazole disodium phosphate injection in patients with intra-abdominal infections caused by anaerobic bacteria: a multicenter, randomized, single-blind, phase IV, non-inferiority trial (ANAEROGUARD study)"],"prefix":"10.1186","volume":"26","author":[{"given":"Lin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rufu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiufang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desheng","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuguang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhuai","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuxiao","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuanghai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youming","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxian","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongtao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiren","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaojiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,28]]},"reference":[{"key":"12789_CR1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13017-021-00387-8","volume":"16","author":"M Sartelli","year":"2021","unstructured":"Sartelli M, Coccolini F, Kluger Y, Agastra E, Abu-Zidan FM, Abbas AES, et al. WSES\/GAIS\/SIS-E\/WSIS\/AAST global clinical pathways for patients with intra-abdominal infections. World J Emerg Surg. 2021;16:49.","journal-title":"World J Emerg Surg"},{"key":"12789_CR2","doi-asserted-by":"crossref","unstructured":"Ross JT, Matthay MA, Harris HW. Secondary peritonitis: principles of diagnosis and intervention. Bmj. 2018;361:k 1407.","DOI":"10.1136\/bmj.k1407"},{"key":"12789_CR3","doi-asserted-by":"crossref","unstructured":"Cobo F. Infections caused by anaerobic Microorganisms. 2021.","DOI":"10.1016\/B978-0-12-818731-9.00065-3"},{"key":"12789_CR4","doi-asserted-by":"publisher","first-page":"6402","DOI":"10.3390\/ijms21176402","volume":"21","author":"B Allam-Ndoul","year":"2020","unstructured":"Allam-Ndoul B, Castonguay-Paradis S, Veilleux A. Gut microbiota and intestinal trans-epithelial permeability. Int J Mol Sci. 2020;21:6402.","journal-title":"Int J Mol Sci"},{"key":"12789_CR5","doi-asserted-by":"publisher","first-page":"940","DOI":"10.3390\/pathogens9110940","volume":"9","author":"GR Pricop","year":"2020","unstructured":"Pricop GR, Gheorghe I, Pircalabioru GG, Cristea V, Popa M, Marutescu L, et al. Resistance and virulence features of bacteroides spp. Isolated from abdominal infections in Romanian patients. Pathogens. 2020;9:940.","journal-title":"Pathogens"},{"key":"12789_CR6","doi-asserted-by":"crossref","unstructured":"Marcus G, Levy S, Salhab G, Mengesha B, Tzuman O, Shur S, et al. Intra-abdominal infections: the role of anaerobes, enterococci, fungi, and multidrug-resistant organisms. Open Forum Infect Dis. 2016;3:ofw232.","DOI":"10.1093\/ofid\/ofw232"},{"key":"12789_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10096-023-04708-4","volume":"43","author":"LJ Dubreuil","year":"2024","unstructured":"Dubreuil LJ. Fifty years devoted to anaerobes: historical, lessons, and highlights. Eur J Clin Microbiol Infect Dis. 2024;43:1\u201315.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"12789_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/sur.2016.261","volume":"18","author":"JE Mazuski","year":"2017","unstructured":"Mazuski JE, Tessier JM, May AK, Sawyer RG, Nadler EP, Rosengart MR, et al. The surgical infection society revised guidelines on the management of intra-abdominal infection. Surg Infect (Larchmt). 2017;18:1\u201376.","journal-title":"Surg Infect (Larchmt)"},{"key":"12789_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1093\/jac\/dkx351","volume":"73","author":"SA Dingsdag","year":"2018","unstructured":"Dingsdag SA, Hunter N. Metronidazole: an update on metabolism, structure-cytotoxicity and resistance mechanisms. J Antimicrob Chemother. 2018;73:265\u201379.","journal-title":"J Antimicrob Chemother"},{"key":"12789_CR10","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.3390\/microorganisms11061474","volume":"11","author":"S Reissier","year":"2023","unstructured":"Reissier S, Penven M, Gu\u00e9rin F, Cattoir V. Recent trends in antimicrobial resistance among anaerobic clinical isolates. Microorganisms. 2023;11:1474.","journal-title":"Microorganisms"},{"key":"12789_CR11","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.ijantimicag.2014.07.027","volume":"44","author":"J Hu","year":"2014","unstructured":"Hu J, Zhang J, Wu S, Zhu D, Huang H, Chen Y, et al. Evaluation of the in vitro activity of levornidazole, its metabolites and comparators against clinical anaerobic bacteria. Int J Antimicrob Agents. 2014;44:514\u201319.","journal-title":"Int J Antimicrob Agents"},{"key":"12789_CR12","first-page":"754","volume":"45","author":"L Ma","year":"2010","unstructured":"Ma L, Zhang YZ, Zheng YL, Wang ZH, Xu YD, Kong LN. Multicenter randomized controlled clinical study on levornidazole and sodium chloride injection in the treatment of pelvic anaerobic infections. Zhonghua Fu Chan Ke Za Zhi. 2010;45:754\u201356.","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"12789_CR13","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1007\/s11596-019-2114-3","volume":"39","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Chen Z, Huang P, Zheng SW, Xu QL, Shi C. Analysis of ornidazole injection in clinical use at post-marketing stage by centralized hospital monitoring system. Curr Med Sci. 2019;39:836\u201342.","journal-title":"Curr Med Sci"},{"key":"12789_CR14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.cbi.2015.09.019","volume":"242","author":"TT Wei","year":"2015","unstructured":"Wei TT, Sun JH, Han LW, Chen K, Wang ZQ, Ji H. Effects of the ornidazole enantiomers on the central nervous system: involvement of the GABAA receptor. Chem Biol Interact. 2015;242:163\u201369.","journal-title":"Chem Biol Interact"},{"key":"12789_CR15","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3390\/biom11020267","volume":"11","author":"AM Rice","year":"2021","unstructured":"Rice AM, Long Y, King SB. Nitroaromatic antibiotics as nitrogen oxide sources. Biomolecules. 2021;11:267.","journal-title":"Biomolecules"},{"key":"12789_CR16","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.talanta.2012.12.007","volume":"106","author":"X Deng","year":"2013","unstructured":"Deng X, Yuan Y, Adams E, Van Schepdael A. Development and validation of a sensitive enantiomeric separation method for new single enantiomer drug levornidazole by CD-capillary electrophoresis. Talanta. 2013;106:186\u201391.","journal-title":"Talanta"},{"key":"12789_CR17","first-page":"90","volume":"53","author":"Z Qian","year":"2018","unstructured":"Qian Z, Li L, Pei H, Wen Z, Fei D, Shu-Tian J, et al. Pharmacokinetics of levornidazole disodium phosphate in monkey. Yaoxue Xuebao. 2018;53:90\u201396.","journal-title":"Yaoxue Xuebao"},{"key":"12789_CR18","unstructured":"National Medical Products Administration. 2021. Available from: https:\/\/www.nmpa.gov.cn\/zwfw\/sdxx\/sdxxyp\/yppjfb\/20210531090806158.html."},{"key":"12789_CR19","first-page":"259","volume":"31","author":"H Xuejun","year":"2016","unstructured":"Xuejun H, Yingzhu X, Yajun D, Hubin W, Hongsha L. Effects of S-(-)-ornidazol disodium phosphate on the nervous system in mice. West China J Pharm Sci. 2016;31:259\u201361.","journal-title":"West China J Pharm Sci"},{"key":"12789_CR20","first-page":"571","volume":"45","author":"X Yanan","year":"2014","unstructured":"Yanan X, Jianguo S, Ping W, Guangji W. Pharmacokinetics of (S)-ornidazole and (S)-ornidazole phosphate disodium in rats. J China Pharm Univ. 2014;45:571\u201375.","journal-title":"J China Pharm Univ"},{"key":"12789_CR21","doi-asserted-by":"publisher","unstructured":"Wang Y, Ji S, You Z, Zhou L, Fang Z, Jia X, et al. Efficacy and safety of levornidazole disodium phosphate for the treatment of pelvic inflammatory disease: a multicenter, double-blind, randomized trial [preprint]. Research Square; 2024 Jul 26 [cited 2024]. Available from:https:\/\/doi.org\/10.21203\/rs.3.rs-4667264\/v1].","DOI":"10.21203\/rs.3.rs-4667264\/v1]"},{"key":"12789_CR22","unstructured":"Chinese Society of Surgical Infection and Intensive Care C, Society of Surgery CMA, Chinese College of Gastrointestimil Fistula Surgeons, Chinese College of Surgeons, Chinese Medical Doctor Association. Chinese guideline for the diagnosis and management of intra-abdominal infection (2019 edition). Chin J Practical Surg. 2020;40:1\u201316."},{"key":"12789_CR23","first-page":"678","volume":"32","author":"T Yun","year":"2017","unstructured":"Yun T, Mingqing T, Hao Y, Yanping L, Mingzhang L, Yongkuan C, et al. The efficacy and safety of morinidazole combined with appendectomy in treating purulent or gangrenous appendicitis: a randomized, controlled, double-blind, multi-center clinical trial. Chin J Gener Surg. 2017;32:678\u201382.","journal-title":"Chin J Gener Surg"},{"key":"12789_CR24","first-page":"879","volume":"35","author":"Z Xin","year":"2020","unstructured":"Xin Z, Yaqiang P, Xin Y. Efficacy of morpholinidazole in elderly patients with suppurative appendicitis. Chin J Gener Surg. 2020;35:879\u201381.","journal-title":"Chin J Gener Surg"},{"key":"12789_CR25","unstructured":"Center for Drug Evaluatiion. National Medical Products Administration. Technical guidance for clinical Trials of antibacterial agents in complicated intra-abdominal infections. 2021. Available from: https:\/\/www.cde.org.cn\/main\/news\/viewInfoCommon\/2214b71bd971f15e1ae16e269986911e."},{"key":"12789_CR26","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1016\/j.clinthera.2018.07.017","volume":"40","author":"H Wu","year":"2018","unstructured":"Wu H, Xie S, Yu J, Chen Y, Wu J, Guo B, et al. Pharmacokinetics and pharmacodynamics of levornidazole in patients with intra-abdominal anaerobicInfection. Clin Ther. 2018;40:1548\u201355.","journal-title":"Clin Ther"},{"key":"12789_CR27","doi-asserted-by":"crossref","unstructured":"Quickfall D, Daneman N, Dmytriw AA, Juurlink DN. Metronidazole-induced neurotoxicity. CMAJ. 2021;193:E1630.","DOI":"10.1503\/cmaj.201671"},{"key":"12789_CR28","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S1665-2681(19)31644-8","volume":"9","author":"B Yilmaz","year":"2010","unstructured":"Yilmaz B, Ekiz F, Y\u00fcksel I, Altinbas A, Deveci M, Y\u00fcksel O. A rare case of recurrent prolonged hepatotoxicity due to ornidazole. Ann Hepatol. 2010;9:305.","journal-title":"Ann Hepatol"},{"key":"12789_CR29","doi-asserted-by":"crossref","unstructured":"L\u00f6fmark S, Edlund C, Nord CE. Metronidazole is still the drug of choice for treatment of anaerobic infections. Clin Infect Dis. 2010;50:S16\u201323.","DOI":"10.1086\/647939"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12789-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12789-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12789-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:03:25Z","timestamp":1781636605000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12789-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,28]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12789"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12789-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,28]]},"assertion":[{"value":"23 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and the International Council for Harmonisation\u2019s Good Clinical Practice guidelines. Approval was obtained from the medical ethics committees of each participating center. All patients provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"719"}}